SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000920465-20-000127
Filing Date
2020-08-06
Accepted
2020-08-06 07:40:47
Documents
58
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ljpc-2020q210xq.htm   iXBRL 10-Q 994516
2 EXHIBIT 31.1 exhibit311fy2020q210-q.htm EX-31.1 14637
3 EXHIBIT 31.2 exhibit312fy2020q210-q.htm EX-31.2 14653
4 EXHIBIT 32.1 exhibit321fy2020q210-q.htm EX-32.1 8600
10 ljpc10qimages0001.jpg GRAPHIC 133541
  Complete submission text file 0000920465-20-000127.txt   4629265

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ljpc-20200630.xsd EX-101.SCH 33150
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ljpc-20200630_cal.xml EX-101.CAL 57748
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ljpc-20200630_def.xml EX-101.DEF 172680
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ljpc-20200630_lab.xml EX-101.LAB 475550
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ljpc-20200630_pre.xml EX-101.PRE 271643
11 EXTRACTED XBRL INSTANCE DOCUMENT ljpc-2020q210xq_htm.xml XML 497747
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36282 | Film No.: 201079862
SIC: 2836 Biological Products, (No Diagnostic Substances)